Polymyxin B Resistance in El Tor Vibrio cholerae Requires Lipid Acylation Catalyzed by MsbB

ABSTRACT Antimicrobial peptides are critical for innate antibacterial defense. Both Gram-negative and Gram-positive microbes have mechanisms to alter their surfaces and resist killing by antimicrobial peptides. In Vibrio cholerae, two natural epidemic biotypes, classical and El Tor, exhibit distinct phenotypes with respect to sensitivity to the peptide antibiotic polymyxin B: classical strains are sensitive and El Tor strains are relatively resistant. We carried out mutant screens of both biotypes, aiming to identify classical V. cholerae mutants resistant to polymyxin B and El Tor V. cholerae mutants sensitive to polymyxin B. Insertions in a gene annotated msbB (encoding a predicted lipid A secondary acyltransferase) answered both screens, implicating its activity in antimicrobial peptide resistance of V. cholerae. Analysis of a defined mutation in the El Tor biotype demonstrated that msbB is required for resistance to all antimicrobial peptides tested. Mutation of msbB in a classical strain resulted in reduced resistance to several antimicrobial peptides but in no significant change in resistance to polymyxin B. msbB mutants of both biotypes showed decreased colonization of infant mice, with a more pronounced defect observed for the El Tor mutant. Mass spectrometry analysis showed that lipid A of the msbB mutant for both biotypes was underacylated compared to lipid A of the wild-type isolates, confirming that MsbB is a functional acyltransferase in V. cholerae.

[1]  M. Venkatesan,et al.  Virulence, Inflammatory Potential, and Adaptive Immunity Induced by Shigella flexneri msbB Mutants , 2009, Infection and Immunity.

[2]  Y. Gho,et al.  Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles. , 2009, Biochimica et biophysica acta.

[3]  M. Trent,et al.  Secondary Acylation of Vibrio cholerae Lipopolysaccharide Requires Phosphorylation of Kdo* , 2009, The Journal of Biological Chemistry.

[4]  J. Kaper,et al.  Vibrio cholerae Flagellins Induce Toll-Like Receptor 5-Mediated Interleukin-8 Production through Mitogen-Activated Protein Kinase and NF-κB Activation , 2008, Infection and Immunity.

[5]  D. Cameron,et al.  A defined transposon mutant library and its use in identifying motility genes in Vibrio cholerae , 2008, Proceedings of the National Academy of Sciences.

[6]  J. Sha,et al.  Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines. , 2008, Microbial pathogenesis.

[7]  M. Hornef,et al.  Developmental switch of intestinal antimicrobial peptide expression , 2008, The Journal of experimental medicine.

[8]  E. Ruby,et al.  Characterization of htrB and msbB Mutants of the Light Organ Symbiont Vibrio fischeri , 2007, Applied and Environmental Microbiology.

[9]  Andrey P. Anisimov,et al.  A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs. , 2007, Vaccine.

[10]  M. McConville,et al.  Secondary Acylation of Klebsiella pneumoniae Lipopolysaccharide Contributes to Sensitivity to Antibacterial Peptides* , 2007, Journal of Biological Chemistry.

[11]  K. Klose,et al.  Identification of Proinflammatory Flagellin Proteins in Supernatants of Vibrio cholerae O1 by Proteomics Analysis*S , 2006, Molecular & Cellular Proteomics.

[12]  J. Mekalanos,et al.  2,3-Butanediol Synthesis and the Emergence of the Vibrio cholerae El Tor Biotype , 2006, Infection and Immunity.

[13]  J. Weiss,et al.  Molecular Basis of Reduced Potency of Underacylated Endotoxins1 , 2005, The Journal of Immunology.

[14]  By Syed Raziuddin Lipopolysaccharides from Vibrio cholerae , 2005 .

[15]  John Turk,et al.  PhoP‐regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B , 2004, Molecular microbiology.

[16]  T. Foster,et al.  Staphylococcus aureus Resists Human Defensins by Production of Staphylokinase, a Novel Bacterial Evasion Mechanism1 , 2004, The Journal of Immunology.

[17]  K. Chaudhuri,et al.  Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. , 2003, Biochimica et biophysica acta.

[18]  M. Baptista,et al.  Attenuated virulence of Streptococcus agalactiae deficient in D‐alanyl‐lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells , 2003, Molecular microbiology.

[19]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[20]  A. Weintraub,et al.  Two msbB Genes Encoding Maximal Acylation of Lipid A Are Required for Invasive Shigella flexneri to Mediate Inflammatory Rupture and Destruction of the Intestinal Epithelium1 , 2002, The Journal of Immunology.

[21]  M. Netea,et al.  Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? , 2002, Trends in immunology.

[22]  Y. Shai,et al.  Mode of action of membrane active antimicrobial peptides. , 2002, Biopolymers.

[23]  H. Flad,et al.  The biology of endotoxin. , 2001, Molecular biotechnology.

[24]  Kenneth Huttner,et al.  Processing site and gene structure for the murine antimicrobial peptide CRAMP , 2001, Peptides.

[25]  B. Zomer,et al.  Modification of Lipid A Biosynthesis inNeisseria meningitidis lpxL Mutants: Influence on Lipopolysaccharide Structure, Toxicity, and Adjuvant Activity , 2001, Infection and Immunity.

[26]  A. Camilli,et al.  Isolation and characterization of a temperature-sensitive generalized transducing bacteriophage for Vibrio cholerae. , 2001, Journal of microbiological methods.

[27]  N. Cianciotto,et al.  Identification of Legionella pneumophila rcp, a pagP-Like Gene That Confers Resistance to Cationic Antimicrobial Peptides and Promotes Intracellular Infection , 2001, Infection and Immunity.

[28]  J. Gunn Bacterial modification of LPS and resistance to antimicrobial peptides , 2001, Journal of endotoxin research.

[29]  R. Hancock,et al.  The role of cationic antimicrobial peptides in innate host defences. , 2000, Trends in microbiology.

[30]  P. Alzari,et al.  Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Darveau,et al.  Escherichia coli msbB Gene as a Virulence Factor and a Therapeutic Target , 1999, Infection and Immunity.

[32]  J. Mekalanos,et al.  In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Samuel I. Miller,et al.  Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo , 1999, Nature Biotechnology.

[34]  G. Georgiou,et al.  Identification of OmpT as the Protease That Hydrolyzes the Antimicrobial Peptide Protamine before It Enters Growing Cells ofEscherichia coli , 1998, Journal of bacteriology.

[35]  S. Miller,et al.  PmrA–PmrB‐regulated genes necessary for 4‐aminoarabinose lipid A modification and polymyxin resistance , 1998, Molecular microbiology.

[36]  W. Shafer,et al.  Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Darveau Lipid A diversity and the innate host response to bacterial infection. , 1998, Current opinion in microbiology.

[38]  J. Kinniburgh Physical and chemical characteristics , 1998 .

[39]  E. Groisman,et al.  Regulation of polymyxin resistance and adaptation to low-Mg2+ environments , 1997, Journal of bacteriology.

[40]  R. Taylor,et al.  Positive selection vectors for allelic exchange. , 1996, Gene.

[41]  A G Marshall,et al.  A high-performance modular data system for Fourier transform ion cyclotron resonance mass spectrometry. , 1996, Rapid communications in mass spectrometry : RCM.

[42]  D. Belin,et al.  Tight regulation, modulation, and high-level expression by vectors containing the arabinose PBAD promoter , 1995, Journal of bacteriology.

[43]  M. Levine,et al.  Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. , 1993, The Journal of infectious diseases.

[44]  M. Levine,et al.  Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. , 1993, Journal of Infectious Diseases.

[45]  E. Groisman,et al.  Resistance to host antimicrobial peptides is necessary for Salmonella virulence. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Lehrer,et al.  Cryptdins: antimicrobial defensins of the murine small intestine , 1992, Infection and immunity.

[47]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[48]  R. Elin,et al.  Biology of endotoxin. , 1976, Annual review of medicine.

[49]  O. Westphal,et al.  Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component. , 1969, European journal of biochemistry.

[50]  O. Westphal,et al.  Biochemical studies on lipopolysaccharides of Salmonella R mutants 5. Evidence for a phosphorylating enzyme in lipopolysaccharide biosynthesis. , 1968, European journal of biochemistry.

[51]  W. Dröge,et al.  Biochemical studies on lipopolysaccharides of Salmonella R mutants. 3. The linkage of the heptose units. , 1968, European journal of biochemistry.

[52]  O. Westphal,et al.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae , 1966 .

[53]  O. Westphal,et al.  Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae. , 1966, Bacteriological reviews.

[54]  O. Westphal Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure , 1965 .